Autenticati per visualizzare i prezzi organizzativi e contrattuali.
Scegli un formato
Cambia visualizzazione
| Taglio della confezione | SKU | Disponibilità | Prezzo |
|---|---|---|---|
| 10 mg | Per conoscere la disponibilità, visualizza il carrello | CHF 182.00 | |
| 50 mg | Per conoscere la disponibilità, visualizza il carrello | CHF 679.00 CHF 577.15 |
Informazioni su questo articolo
Formula empirica (notazione di Hill):
C19H19ClN2
Numero CAS:
Peso molecolare:
310.82
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.32
MDL number:
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutartiNome del prodotto
Desloratadine, powder, ≥98% (HPLC)
Quality Level
assay
≥98% (HPLC)
form
powder
solubility
DMSO: >10 mg/mL
storage temp.
2-8°C
SMILES string
Clc1ccc2c(CCc3cccnc3\C2=C4\CCNCC4)c1
InChI
1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2
InChI key
JAUOIFJMECXRGI-UHFFFAOYSA-N
Gene Information
human ... HRH1(3269)
Application
Desloratadine has been used to test its effect on embryoid body development in in vitro gastrulation model of P19C5 stem cells. It has also been used as an antihistamine mimic in rats and to treat lung cancer (A549) and glioblastoma (U87) cells in various cellular studies.
Biochem/physiol Actions
A non-sedating H1-receptor antagonist, free from antimuscarinic/anticholinergic effects. It has novel antiallergic and anti-inflammatory effects.
Desloratadine is a selective and nonsedating histamine H1 receptor antagonist, an active metabolite of loratadine (Claritin), used to relieve hay fever and allergy symptoms with less drowsiness than other antihistamines; does not significantly inhibits cardiac K+ channels at clinically achievable blood levels. Free from antimuscarinic/anticholinergic effects.
Legal Information
Clarinex is a registered trademark of Schering Corp.
1 of 1
Questo articolo | |||
|---|---|---|---|
| assay ≥98% (HPLC) | assay - | assay - | assay - |
| Quality Level 100 | Quality Level 300 | Quality Level - | Quality Level - |
| form powder | form - | form - | form - |
| storage temp. 2-8°C | storage temp. 2-30°C | storage temp. - | storage temp. 2-8°C |
| Gene Information human ... HRH1(3269) | Gene Information human ... HRH1(3269) | Gene Information human ... HRH1(3269) | Gene Information human ... HRH1(3269) |
| solubility DMSO: >10 mg/mL | solubility - | solubility - | solubility - |
Still not finding the right product?
Explore all of our products under Desloratadine
Classe di stoccaggio
11 - Combustible Solids
wgk
WGK 1
flash_point_f
390.2 °F - Pensky-Martens closed cup
flash_point_c
199 °C - Pensky-Martens closed cup
Scegli una delle versioni più recenti:
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Contenuto correlato
Lysosomal Destabilizing Drug Siramesine and the Dual Tyrosine Kinase Inhibitor Lapatinib Induce a Synergistic Ferroptosis through Reduced Heme Oxygenase-1 (HO-1) Levels
Villalpando-Rodriguez GE, et al.
Oxidative Medicine and Cellular Longevity, 2019 (2019)
Translational Physiology: Prolonged intake of desloratadine: mesenteric lymphatic vessel dysfunction and development of obesity/metabolic syndrome
Gasheva OY, et al.
The American Journal of Physiology, 316(1), G217-G217 (2019)
Nicholas Cutrona et al.
ACS infectious diseases, 5(8), 1397-1410 (2019-05-28)
Staphylococcus epidermidis and Staphylococcus aureus are important human pathogens responsible for two-thirds of all postsurgical infections of indwelling medical devices. Staphylococci form robust biofilms that provide a reservoir for chronic infection, and antibiotic-resistant isolates are increasingly common in both healthcare
Numero articolo commerciale globale
| SKU | GTIN |
|---|---|
| D1069-50MG | 04061833558522 |
| D1069-10MG | 04061833558515 |
